Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer
Clinical trial NCT02077335 · UNKNOWN
Trial details
- NCT number
- NCT02077335
- Sponsor
- CSSS de Gatineau
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2026-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.